¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Gerhardt test for acetoacetic acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • solubility test
    ¿ëÇØµµ°Ë»ç
  • specific gravity test
    ºñÁß°Ë»ç
  • spot test
    Á¡Àû°Ë»ç
  • stamp test
    ¿ìÇ¥ÆÄ¿­°Ë»ç
  • station test
    Á¤Áö°Ë»ç
  • Schick test
    ½ÃÅ©°Ë»ç(¹ý)
  • Schilling test
    ½Ç¸µ°Ë»ç
  • stimulation test
    Àڱذ˻ç
  • stool guaiac test
    ´ëº¯ÀáÇ÷°Ë»ç
  • stress test
    ºÎÇϰ˻ç, Àڱذ˻ç
  • Student t test
    ½ºÅõµ§Æ®t°ËÁ¤
  • sweat test
    ¶¡°Ë»ç
  • swinging flashlight test
    ±³´ëºÒºû°Ë»ç
  • scratch test
    ±ÜÀºÀÚ±¹°Ë»ç
  • screening test
    ¼±º°°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®¸£»êȸ·Î
  • tricarboxylic acid cycle
    »ïÄ«¸£º¹½Ç»êȸ·Î
  • nucleic acid hybridization
    ÇÙ»êºÎÇÕÈ­
  • uric acid infarct
    ¿ä»ê°æ»ö
  • nucleic acid probe
    ÇÙ»ê´õµëÀÚ
  • uric acid nephropathy
    (¢¡urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
  • periodic acid-Schiff stain
    ÇÇ¿¡ÀÌ¿¡½º¿°»ö
  • uric acid stone
    ¿ä»êµ¹
  • abrasion test
    ¸¶¸ê½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • acceptance test
    Àμö°Ë»ç
  • achievement test
    ¼ºÃëµµ°Ë»ç
  • adsorption test
    ÈíÂø½ÃÇè, ºÎÂø°Ë»ç
  • afterimage test
    ÀÜ»ó°Ë»ç
  • agar gel precipitin inhibition test
    ¿ì¹«°Öħ°­¼Ò¾ïÁ¦°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • glycocholic acid
    ±Û¸®ÄÚÄÝ»ê.
  • glycolic acid
    ±Û¶óÀÌÄÝ»ê
  • gout,uric acid stones
    ¿ä»ê°á¼®
  • guanylic acid deaminase
    ±¸¾Æ´Ò»êµ¥¾Æ¹Ì³ª Á¦.
  • hemopyrrole carboxylic acid
    Çì¸ðÇÇ·ÑÄ«¸£º¹½Ç»ê.
  • heteropoly acid
    ÇìÅ׷δÙÁß»ê(¡­Òýñìß«).
  • hippuric acid
    È÷Ǫ¸£»ê, ¸¶´¢»ê.
  • histamine acid phosphate
    È÷½ºÅ¸¹Î»ê¼ºÀλ꿰
  • homogentisic acid
    È£¸ðÁ¨Æ¾»ê.
  • homogentisic acid
    È£¸ð°ÕƼ½Å»ê, Homogentisin »ê
  • homogentisic acid
    È£¸ð°ÕƼ½Å»ê
  • homogentisic acid oxidase
    È£¸ð°ÕƼ½Å»ê »êÈ­È¿¼Ò(¡­ß«ß«ûùý£áÈ).
  • homogentisic acid oxidase
    È£¸ð°ÕƼ½Å»ê»êÈ­È¿¼Ò
  • homopilopic acid
    È£¸ðÇÊ·ÎÇÁ»ê.
  • homovanillic acid
    È£¸ð¹Ù´Ò¸°»ê
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®·Î»êȸ·Î.
  • citric acid cycle
    ±¸¿¬»êȸ·Î
  • conjugate acid
    °áÇÕ»ê(Ì¿ùêß«)
  • conjugate acid
    ¦»ê(¡­ß«).
  • conjugated acid
    ¦»ê, °ø¾×»ê, °áÇÕ»ê.
  • corrosive acid
    ºÎ½Ä»ê(ݯãÚß«).
  • cyanuric acid
    ½Ã¾Æ´©¸£»ê(¡­ß«).
  • cyclopaldic acid
    ½ÃŬ·ÎÆÈµå»ê(¡­ß«).
  • dehydroascorbic acid
    Å»¼ö¼Ò¾Æ½ºÄÚ¸£ºó»ê.
  • delta-aminolevulinic acid
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»ê
  • delta-aminolevulinic acid
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»ê.
  • delta-aminolevulinic acid dehydrase
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»êÅ»¼ö¼ÒÈ¿¼Ò<--µ¥È÷µå¶óÁ¦>
  • delta-aminolevulinic acid dehydrogenase
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»êÅ»¼ö¼ÒÈ¿¼Ò<--µðÇÏÀ̵å·Î°Ô³ªÁ¦>
  • delta-aminolevulinic acid synthetase
    µ¨Å¸-¾Æ¹Ì³ë·¹ºÒ¸°»êÇÕ¼ºÈ¿¼Ò
  • deoxycholic acid
    µ¥¿Á½ÃÄݸ°»ê
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • CBZ-amino acid
    (å²) carbobenzoxy-¾Æ¹Ì³ë»ê(ß«)
  • cell-free amino acid incorporating system
    ¹«¼¼Æ÷(Ùíá¬øà) ¾Æ¹Ì³ë»ê ÆíÀÔ(øºìý)¾¾½ºÅÛ
  • cerotic acid
    ¼¼·ÎÆ®»ê(ß«)
  • cevitaminic acid
    ¼¼ºñŸ¹Î »ê(ß«)
  • charged polar amino acid
    ±Ø¼º(пàü) ¾Æ¹Ì³ë»ê(ß«)
  • chaulmoogric acid
    Â÷¿ï¹«±×¸£»ê(ß«)
  • chenic acid
    þ»ê(ß«)
  • chenodeoxycholic acid
    Ű³ëµð¿Á½ÃÄݸ° »ê(ß«)
  • p-chloromercuribenzoic acid
    p-Ŭ·Î·Î¸ÓÅ¥¸®º¥Á¶»ê(ß«)
  • choleic acid
    ÄÝ·¹»ê(ß«)
  • cholic acid
    ÄÝ»ê(ß«)
  • chorismic acid
    ÄÚ¸®½¿»ê(ß«)
  • citric acid
    ½ÃÆ®¸£»ê(ß«)
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • concerted acid-base catalysis
    Çùµ¿ »ê¿°±â Ã˸Å(úðÔÒß«ç¤ÐñõºØÚ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
BAO-MAO basal acid output to maximal acid output [ratio]
cDNA circular deoxyribonucleic acid; complementary deoxyribonucleic acid
DPA D-penicillamine; Department of Public Assistance; diphenylalanine; dipicolinic acid; dipropylacetic ...
EAA electroacupuncture analgesia; Epilepsy Association of America; essential amino acid; excitatory amin...
FAA folic acid antagonist; formaldehyde, acetic acid, alcohol
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
ETT Exercise Tolerance Test
ET Exercise test
FECRT Faecal egg count reduction test
FOBT Faecal occult blood test
FTND Fagerstrom Test for Nicotine Dependence
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
    ¿À¸£Åä ÀλêÀ» 200-300µµ·Î ¿À·¡ °¡¿­ÇÒ ¶§ »ý±â´Â Å« °áÁ¤.
  • pyruvic acid
    ÆÄÀÌ·çºó»ê, Ãʼº Æ÷µµ»ê
    ź¼öÈ­¹° ´ë»çÀÇ Áß°£ ¹°Áú. ¶ó½Ã¹Ì »êÀ̳ª ÁÖ¼®»êÀÇ °Ç·ù¿¡ ÀÇÇØ »ý¼ºµÉ ¼ö ÀÖ´Ù.
  • quinaldinic acid
    Ű³¯µò»ê
  • quinolinic acid
    Ű³î¸°»ê
    ¹«»öÀÇ ÁÖ»ó °áÁ¾À¸·Î, Ű³î¸°ÀÇ »êÈ­ »ý¼º¹°.
  • ribonucleic acid
    ¸®º¸ ÇÙ»ê
    È¿¸ð¿¡¼­ óÀ½À¸·Î ºÐ¸®µÈ ÇÙ»êÀ¸·Î ³ªÁß¿¡´Â ¸ðµç »ì¾ÆÀÖ´Â ¼¼Æ÷¿¡¼­µµ ¹ß°ßµÇ¾ú´Ù. °¡¼öºÐÇØÇÏ¸é ¾Æµ¥´Ñ, ±¸¾Æ´Ñ, »çÀÌÅä½Å, ¿ì¶ó½Ç, ¶ûº¸½º, ÀλêÀÌ »ý±ä´Ù. RNA¶ó ¾à±âÇÑ´Ù.
  • saccharic acid
    »çÄ«¸°»ê, ´ç»ê, »èÄ«¸°»ê
    1. ÀÌ¿°±â»ê. COOH,
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê
  • serum bile acid
    Ç÷û ´ãÁó»ê
    ¹Ì·® Á¸ÀçÇÑ´Ù.
  • serum free fatty acid
    Ç÷û À¯¸® Áö¹æ»ê Á¤·®
    Á¤»óÄ¡´Â Á¶±â °øº¹ ½Ã 200-600¥ìEq/l·Î »ý¸®Àû º¯µ¿ÀÌ Å©´Ù.
  • serum uric acid
    Ç÷û ´¢»ê
    Åëdz, ½ÅºÎÀü, ¹éÇ÷º´ µîÀ¸·Î °í´¢»êÁõÀÌ »ý±ä´Ù.
  • sialic acid
    Ÿ¾×»ê
    ¸¹Àº ¹ÂÄÚ ´Ù´ç·ù¿Í ´çÁöÁú Áß¿¡ Á¸ÀçÇÏ´Â ´º¶ó¹Î»êÀÇ À¯µµÃ¼.
  • silicic acid
    ±Ô»ê
    ±Ô¼Ò¸¦ ¿°±â·Î ÇÏ¿© ±Ô»ê¿°À» Çü¼ºÇÏ´Â °ÍÀ¸·Î ortho ±Ô»ê, meta ±Ô»ê,
  • silicic acid anhydride
    ¹«¼ö ±Ô»ê
  • silicotungstic acid
    ½Ç¸®ÄÚ ÅÖ½ºÅÙ»ê
    ¹é»ö ¶Ç´Â Ȳ»öÀÇ °áÁ¤. ¾ËÄ®·ÎÀÌµå ½Ã¾àÀ¸·Î ¾²ÀδÙ.
  • sorbic acid
    ¼Ò¸£ºó»ê
    sorbus aucu
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
Master test An early and long-used exercise challenge to identify ischemic heart disease using a pair of nine inch steps with a platform on top, the number of trips by the patient arbitrarily chosen and related to age and body weight.
See: two-step exercise test.
Synonym: Master's two-step exercise test.
(05 Mar 2000)
red cell adherence test The diagnostic application of the immune adhesion phenomenon.
Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test.
(05 Mar 2000)
Casoni intradermal test A test for hydatid disease in which hydatid fluid is injected intracutaneously; immediate or delayed wheal and flare reaction is positive.
Synonym: Casoni skin test.
(05 Mar 2000)
Casoni skin test A test for hydatid disease in which hydatid fluid is injected intracutaneously; immediate or delayed wheal and flare reaction is positive.
Synonym: Casoni skin test.
(05 Mar 2000)
red test An obsolete test for renal function; after the patient has drunk a glass or two of water, 1 ml of a 0.6% solution of dye is injected hypodermically; the time between this injection and the appearance of a pink tinge in the urine as it falls into an alkaline solution is noted; the amount excreted in each of the next 2 hours is then estimated colourimetrically.
Synonym: Geraghty's test, phthalein test, red test, Rowntree and Geraghty test.
(05 Mar 2000)
viability test <investigation> Test to determine the proportion of living individuals, cells or organisms, in a sample. Viability tests are most commonly performed on cultured cells and usually depend on the ability of living cells to exclude a dye, (an exclusion test) or to specifically take it up (inclusion test).
(18 Nov 1997)
Mauthner's test An obsolete test for colour perception similar to Holmgren's, but made with vials filled with pigments instead of with skeins of wool.
(05 Mar 2000)
maximal Histalog test A test for measurement of maximal production of gastric acidity or anacidity; it is similar to the histamine test, but uses Histalog (betazole hydrochloride), an analogue of histamine.
Synonym: maximal Histalog test.
(05 Mar 2000)
Mazzotti test A test for onchocerciasis using an oral test dose of diethylcarbamazine (50 or 100 mg), resulting in the appearance of an acute rash in 2 to 24 hours from death of microfilariae in the skin.
Synonym: Mazzotti reaction.
(05 Mar 2000)
McMurray test Rotation of the tibia on the femur to determine injury to meniscal structures.
(05 Mar 2000)
McNemar's test A form of chi-square test for matched paired data.
(05 Mar 2000)
McPhail test A test for progesterone and like substances; immature female rabbits are treated with 150 IU of estrone over a period of 6 days; the test material is then given in five daily subcutaneous doses; progestational proliferation of the endometrium is noted and the results estimated according to a scale from 0 to ++++; the amount required to produce an average (++) response is taken as a unit, equivalent to 0.25 mg of progesterone.
(05 Mar 2000)
passive cutaneous anaphylaxis test An animal is injected intradermally with antibody (usually IgE) and subsequently challenged intravenously with a mixture of antigen and Evans blue dye 24-48 hours later. A dark blue area indicates a positive reaction due to the leakage of the dye at the site of antigen-antibody reactions.
(05 Mar 2000)
patch test A test of skin sensitiveness: a small piece of paper, tape, or a cup, wet with CO non-irritating diluted test fluid, is applied to skin of the upper back or upper outer arm and after 48 hours the area previously covered is compared with the uncovered surface; an erythematous reaction with vesicles occurs if the substance causes contact allergy.
See: photo-patch test.
(05 Mar 2000)
Reinsch's test A test for arsenic in which a strip of copper is placed in the suspected fluid, which is then acidulated with hydrochloric acid and boiled; if arsenic is present a gray deposit occurs on the copper, and this deposit on heating is sublimated and deposited as a crystalline layer on a piece of glass held above the copper strip.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á